China
Africa
Explore chapters and articles related to this topic
Treating Anxiety in Cancer Patients
Published in Scott Temple, Brief Cognitive Behavior Therapy for Cancer Patients, 2017
The use of screening instruments, including the ESAS-R and the Generalized Anxiety Disorder Scale (GAD-7), in addition to a handoff by other members of the treatment team, allows the therapist to home in on relevant patient concerns in the first session. One can further assess worry, as needed, by using the Penn State Worry Questionnaire (Meyer et al., 1990) or the Metacognitions Questionnaire 30 (MCQ-30) (Wells, 2009). Assessment of the patient also requires explaining to patients what treatment options are available, with what evidence base for each. While the focus of this book is on psychotherapy, the use of medication to manage depression and anxiety is also routinely offered as an option. Patient preferences for one treatment over another, or in combination, should always be taken into account. Patients who are immediately facing highly distressing diagnoses and procedures, and for whom distress tolerance is limited, may benefit considerably from at least the short-term use of anxiolytics and/or SSRIs or other anti-depressant/anti-anxiety medications. Similarly, when significant sleep difficulties are intruding on adaptive functioning, medication on perhaps a short-term basis can be a value adjunct to treatment. It is advisable to work collaboratively with the oncology teams on questions of medication; many oncology teams have medical oncologists, psychiatrists, physician’s assistants, or doctoral-level nurses who are comfortable prescribing anti-depressants and anti-anxiety medications.
Metacognitions in Triathletes: Associations With Attention, State Anxiety, and Relative Performance
Published in Journal of Applied Sport Psychology, 2018
Steven Love, Lee Kannis-Dymand, Geoff P. Lovell
In their S-REF model, Wells and Matthews (1996) proposed that the Cognitive Attention Syndrome is consequent from two categories of underlying metacognitive beliefs. Positive beliefs are concerned with the functional value of perseverative thinking, whereas negative beliefs involve content related to the consequences and control of preservative thinking. Research has since utilized the Metacognitions Questionnaire (MCQ-30; Wells & Cartwright-Hatton, 2004), which is concerned with such beliefs, to investigate their relationship to various psychopathology, including various anxiety disorders, depression, obsessive compulsive disorder, psychosis, schizophrenia, personality disorders, and eating disorders (Sun, So, Zhu, & Leung, 2016; Wells, 2009, 2013, 2014). In a recent study, Sun et al., 2016 performed a meta-analysis on 43 studies involving the MCQ-30 and various psychopathology and found that all five subscales of the MCQ-30 had large combined effect sizes, indicating that clinical populations are more likely to possess higher dysfunctional metacognitive beliefs.
The association of metacognitive beliefs with emotional distress and trauma symptoms in adolescent and young adult survivors of cancer
Published in Journal of Psychosocial Oncology, 2018
Peter L. Fisher, Kirsten McNicol, Mary Gemma Cherry, Bridget Young, Ed Smith, Gareth Abbey, Peter Salmon
Metacognitive beliefs were assessed using the 30-item self-report Metacognitions Questionnaire-30 (MCQ-30) (Wells & Cartwright-Hatton, 2004), which assesses five dimensions of metacognition. Respondents are asked to rate whether they ‘‘generally agree” with each statement using a 4-point scale, with options extending from 1 (“do not agree”) to 4 (“agree very much”). Responses are summed to give subscale scores (ranging from 6 to 24) and a total score (ranging from 30 to 120), with higher scores indicating higher levels of unhelpful metacognitions. The MCQ-30 has been validated for use with cancer patients (Cook et al., 2015, Cook, Salmon, Dunn, & Fisher, 2014), with the exception of the ‘Need to Control Thoughts' subscale (Cronbach's α = 0.64), all subscales demonstrated very good internal consistency in this study (all Cronbach's α > 0.80).
The effect of thought importance on stress responses: a test of the metacognitive model
Published in Stress, 2018
Lora Capobianco, Anthony P. Morrison, Adrian Wells
Metacognitions Questionnaire (MCQ-30; Wells & Cartwright-Hatton, 2004). The MCQ-30 measures individual differences in metacognitive beliefs, judgments and monitoring tendencies. There are five subscales, which include: cognitive confidence (i.e. “I have little confidence in my memory for places.”), positive beliefs about worry (i.e. “I need to worry in order to remain organized.”), cognitive self-consciousness (i.e. “I think a lot about my thoughts.”), negative beliefs about uncontrollability of thoughts and danger, (i.e. “My worrying could make me go mad.”) and beliefs about the need to control thoughts (i.e. “It is bad to think certain thoughts.”). The MCQ-30 subscales demonstrate good internal consistency (Cronbach alphas .72–.93), convergent validity and acceptable test–retest reliability (Spada et al., 2008; Wells & Cartwright-Hatton, 2004). It was used in this study to evaluate and if necessary control potential differences between the groups.